Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2016, Article ID 7370524, 11 pages
http://dx.doi.org/10.1155/2016/7370524
Review Article

Hepatitis C Virus in North Africa: An Emerging Threat

1Department of Medical Microbiology, Faculty of Medicine, Tripoli University, P.O. Box 82668, Tripoli, Libya
2Department of Laboratory Medicine, Faculty of Biotechnology, Tripoli University, P.O. Box 82668, Tripoli, Libya
3Department of Microbiology and Parasitology, Faculty of Veterinary Medicine, Tripoli University, P.O. Box 13662, Tripoli, Libya
4Department of Surgery, Tripoli Medical Centre, Faculty of Medicine, Tripoli University, P.O. Box 82668, Tripoli, Libya
5Department of Pharmacology, Faculty of Medical Technology, Algabal Algarbi University, P.O. Box 3321, Nalut, Libya

Received 6 April 2016; Revised 21 June 2016; Accepted 19 July 2016

Academic Editor: Anna Linda Zignego

Copyright © 2016 Mohamed A. Daw et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Thomas, “Global control of hepatitis C: where challenge meets opportunity,” Nature Medicine, vol. 19, no. 7, pp. 850–858, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Lazarus, Global Policy Report on the Prevention and Control of Viral Hepatitis in Who Member States, World Health Organization, Geneva, Switzerland, 2014.
  3. V. Madhava, C. Burgess, and E. Drucker, “Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa,” The Lancet Infectious Diseases, vol. 2, no. 5, pp. 293–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Onyekwere and L. Hameed, “Hepatitis B and C virus prevalence and association with demographics: report of population screening in Nigeria,” Tropical Doctor, vol. 45, no. 4, pp. 231–235, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. H. S. Te and D. M. Jensen, “Epidemiology of hepatitis B and C viruses: a global overview,” Clinics in Liver Disease, vol. 14, no. 1, pp. 1–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Negro and A. Alberti, “The global health burden of hepatitis C virus infection,” Liver International, vol. 31, no. 2, pp. 1–3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-M. Pawlotsky, “New hepatitis C therapies: the toolbox, strategies, and challenges,” Gastroenterology, vol. 146, no. 5, pp. 1176–1192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Riou, M. Aït Ahmed, A. Blake et al., “Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis,” Journal of Viral Hepatitis, vol. 23, pp. 244–255, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Daw, A. El-Bouzedi, and A. A. Dau, “Libyan armed conflict 2011: mortality, injury and population displacement,” African Journal of Emergency Medicine, vol. 5, no. 3, pp. 101–107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Baha, A. Foullous, N. Dersi et al., “Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco,” BMC Public Health, vol. 13, article 50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Daw and A. El-Bouzedi, “Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey,” BMC Infectious Diseases, vol. 14, article 17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Guerra, M. Garenne, M. K. Mohamed, and A. Fontanet, “HCV burden of infection in Egypt: results from a nationwide survey,” Journal of Viral Hepatitis, vol. 19, no. 8, pp. 560–567, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Daw and A. A. Dau, “Hepatitis C virus in Arab world: a state of concern,” The Scientific World Journal, vol. 2012, Article ID 719494, 12 pages, 2012. View at Publisher · View at Google Scholar
  14. M. A. Daw, “Transmission of hepatitis C Virus,” in Hepatitis C Virus: Molecular Pathways and Treatments, O. Stambouli, Ed., OMICS Group, Henderson, Nev, USA, 2014. View at Google Scholar
  15. M. A. Daw, M. A. Elkaber, A. M. Drah, M. M. Werfalli, A. A. Mihat, and I. M. Siala, “Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk,” Saudi Medical Journal, vol. 23, no. 11, pp. 1356–1360, 2002. View at Google Scholar · View at Scopus
  16. W. A. Alashek, C. W. McIntyre, and M. W. Taal, “Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors,” BMC Infectious Diseases, vol. 12, article 265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Daw, A. El-Bouzedi, and A. A. Dau, “Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission,” BMC Research Notes, vol. 8, article 367, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. H. A. Elasifer, Y. M. Agnnyia, B. A. Al-Alagi, and M. A. Daw, “Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients,” Virology Journal, vol. 7, article 317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Triki, N. Said, A. B. Salah et al., “Seroepidemiology of hepatitis B, C and delta viruses in Tunisia,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 1, pp. 11–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Mejri, A. Ben Salah, H. Triki, N. Ben Alaya, A. Djebbi, and K. Dellagi, “Contrasting patterns of hepatitis C virus infection in two regions from Tunisia,” Journal of Medical Virology, vol. 76, no. 2, pp. 185–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Kaabia, E. Ben Jazia, I. Slim et al., “Association of hepatitis C virus infection and diabetes in central Tunisia,” World Journal of Gastroenterology, vol. 15, no. 22, pp. 2778–2781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Ben Jemia and E. Gouider, “Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia,” Transfusion Clinique et Biologique, vol. 21, no. 6, pp. 303–308, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Debbeche, Y. Said, H. Ben Temime et al., “Epidémiologie de l'hépatite C en Tunisie,” La Tunisie Medicale, vol. 91, no. 2, pp. 86–91, 2013. View at Google Scholar
  24. F. Sassi, Y. Gorgi, K. Ayed, T. B. Abdallah, A. Lamouchi, and H. B. Maiz, “Hepatitis C virus antibodies in dialysis patients in Tunisia: a single center study,” Saudi Journal of Kidney Diseases and Transplantation, vol. 11, pp. 218–222, 2000. View at Google Scholar
  25. A. Djebbi, H. Triki, O. Bahri et al., “Genotypes of hepatitis C virus circulating in Tunisia,” Epidemiology and Infection, vol. 130, no. 3, pp. 501–505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. F. H. Kchouk, Y. Gorgi, L. Bouslama et al., “Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients,” Viral Immunology, vol. 26, no. 1, pp. 40–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bensalem, K. Selmani, N. Hihi et al., “Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012,” Journal of Medical Virology, vol. 88, no. 8, pp. 1394–1403, 2016. View at Publisher · View at Google Scholar
  28. National Travel Health Network Centre (NATHNAC), Country Information, Algeria, Tunisia, Morocco, 2009.
  29. Z. Ayed, D. Houinato, M. Hocine, S. Ranger-Rogez, and F. Denis, “Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria,” Bulletin de la Société de Pathologie Exotique, vol. 88, no. 5, pp. 225–228, 1995. View at Google Scholar · View at Scopus
  30. S. Rouabhia, M. Sadelaoud, K. Chaabna-Mokrane, W. Toumi, and L. Abenavoli, “Hepatitis C virus genotypes in north eastern Algeria: a retrospective study,” World Journal of Hepatology, vol. 5, no. 7, pp. 393–397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Benjelloun, B. Bahbouhi, S. Sekkat, A. Bennani, N. Hda, and A. Benslimane, “Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups,” Research in Virology, vol. 147, no. 4, pp. 247–255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Boutayeb, A. Aamoum, and N. Benchemsi, “Connaissances sur les virus des hépatites B et C et le VIH chez des donneurs de sang à Casablanca,” Eastern Mediterranean Health Journal, vol. 12, no. 5, pp. 538–547, 2006. View at Google Scholar
  33. B. O. M. Abdelaali, D. Taoufik, A. Samir, and M. Saad, “Hepatitis C viral prevalence and seroconversion in Moroccan hemodialysis units: eight year follow up,” Journal of Medical Diagnostic Methods, vol. 2, p. 141, 2013. View at Publisher · View at Google Scholar
  34. I. Belbacha, I. Cherkaoui, M. Akrim, K. E. Dooley, and R. El Aouad, “Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco,” Eastern Mediterranean Health Journal, vol. 17, no. 12, pp. 911–919, 2011. View at Google Scholar · View at Scopus
  35. R.-D. Trimbitas, F. Z. Serghini, F. Lazaar et al., “The ‘hidden’ epidemic: a snapshot of Moroccan intravenous drug users,” Virology Journal, vol. 11, no. 1, article 43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Brahim, A. Akil, E. M. Mtairag et al., “Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades,” Archives of Virology, vol. 157, no. 3, pp. 515–520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Lunel-Fabiani, W. Mansour, A. O. Amar et al., “Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study,” The Journal of Infection, vol. 67, no. 5, pp. 448–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Mansour, M.-A. Bollahi, C.-T. Hamed et al., “Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania,” Journal of Clinical Virology, vol. 55, no. 1, pp. 12–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Mansour, F.-Z. F. Malick, A. Sidiya et al., “Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania,” Journal of Medical Virology, vol. 84, no. 8, pp. 1186–1198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Estes, M. Abdel-Kareem, W. Abdel-Razek et al., “Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies,” Alimentary Pharmacology & Therapeutics, vol. 42, no. 6, pp. 696–706, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. D. A. Saleh, F. M. Shebl, S. S. El-Kamary et al., “Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 5, pp. 357–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Breban, W. Doss, G. Esmat et al., “Towards realistic estimates of HCV incidence in Egypt,” Journal of Viral Hepatitis, vol. 20, no. 4, pp. 294–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. F. D. Miller, M. S. Elzalabany, S. Hassani, and D. F. Cuadros, “Epidemiology of hepatitis C virus exposure in Egypt: opportunities for prevention and evaluation,” World Journal of Hepatology, vol. 7, no. 28, pp. 2849–2858, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Medhat, M. Shehata, L. S. Magder et al., “Hepatitis C in a community in Upper Egypt: risk factors for infection,” The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 5, pp. 633–638, 2002. View at Google Scholar · View at Scopus
  45. O. Okasha, A. Munier, E. Delarocque-Astagneau et al., “Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt,” Eastern Mediterranean Health Journal, vol. 21, no. 3, pp. 199–212, 2015. View at Google Scholar · View at Scopus
  46. C. R. Kenyon and R. Colebunders, “The association between female genital cutting and spousal HCV infection in Egypt,” International Journal of Hepatology, vol. 2014, Article ID 164357, 10 pages, 2014. View at Publisher · View at Google Scholar
  47. M. K. Mohlman, D. A. Saleh, S. Ezzat et al., “Viral transmission risk factors in an Egyptian population with high hepatitis C prevalence,” BMC Public Health, vol. 15, article 1030, 2015. View at Publisher · View at Google Scholar
  48. M. Abdel-Hamid, M. El-Daly, V. Molnegren et al., “Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma,” The Journal of General Virology, vol. 88, no. 5, pp. 1526–1531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Breban, N. Arafa, S. Leroy et al., “Effect of preventive and curative interventions on hepatitis c virus transmission in Egypt (ANRS 1211): a modelling study,” The Lancet Global Health, vol. 2, no. 9, pp. e541–e549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Hierholzer, R. R. Graham, I. El Khidir et al., “HIV type 1 strains from East and West Africa are intermixed in Sudan,” AIDS Research and Human Retroviruses, vol. 18, no. 15, pp. 1163–1166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. H. M. Mudawi, “Epidemiology of viral hepatitis in Sudan,” Clinical and Experimental Gastroenterology, vol. 1, pp. 9–13, 2008. View at Publisher · View at Google Scholar
  52. E. A. Osman, N. A. Abdulrahman, O. Abbass, W. H. Omer, and H. A. Saad, “Prevalence of Hepatitis B surface antigen and Hepatitis C virus antibodies among pre-surgery screened patients in Khartoum, Central Sudan,” Journal of General and Molecular Virology, vol. 4, pp. 6–9, 2012. View at Google Scholar
  53. H. M. Y. Mudawi, H. M. Smith, I. A. Fletcher, and S. S. Fedail, “Prevalence and common genotypes of HCV infection in sudanese patients with hepatosplenic schistosomiasis,” Journal of Medical Virology, vol. 79, no. 9, pp. 1322–1324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. M. Ismail, A. A. Eisa, and F. Ibrahim, “HIV-infected people in Sudan moving toward chronic poverty: possible interventions,” Journal of the Association of Nurses in AIDS Care, vol. 27, no. 1, pp. 30–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. United Nations Office on Drugs and Crime, World Drug Report, 2007, https://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html.
  56. C. Cook and N. Kanaef, The Global State of Harm Reduction 2008: Mapping the Response to Drug-related HIV and Hepatitis C Epidemics, International Harm Reduction Association, 2008.
  57. P. K. Nelson, B. M. Mathers, B. Cowie et al., “Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews,” The Lancet, vol. 378, no. 9791, pp. 571–583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. G. R. Mumtaz, H. A. Weiss, S. L. Thomas et al., “HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis,” PLoS Medicine, vol. 11, no. 6, Article ID e1001663, pp. 1–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Mumtaz, N. Hilmi, W. McFarland et al., “Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis,” PLoS Medicine, vol. 8, Article ID e1000444, 2011. View at Publisher · View at Google Scholar
  60. E. Alirol, L. Getaz, B. Stoll, F. Chappuis, and L. Loutan, “Urbanisation and infectious diseases in a globalised world,” The Lancet Infectious Diseases, vol. 11, no. 2, pp. 131–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Malik and B. Awadallah, “The economics of the Arab Spring,” World Development, vol. 45, pp. 296–313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Zakaria, R. Fouad, O. Shaker et al., “Changing patterns of acute viral hepatitis at a major urban referral center in Egypt,” Clinical Infectious Diseases, vol. 44, no. 4, pp. e30–e36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. M. A. Nafeh, A. Medhat, M. Shehata et al., “Hepatitis C in a community in upper Egypt: I. Cross-sectional survey,” American Journal of Tropical Medicine and Hygiene, vol. 63, no. 5-6, pp. 236–241, 2000. View at Google Scholar · View at Scopus
  64. M. A. Daw, A. A. Dau, and M. M. Agnan, “Influence of healthcare-associated factors on the efficacy of hepatitis C therapy,” The Scientific World Journal, vol. 2012, Article ID 580216, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. M. A. Daw, A. El-Bouzedi, and A. A. Dau, “The assessment of efficiency and coordination within the Libyan health care system during the armed conflict-2011,” Clinical Epidemiology and Global Health, 2015. View at Publisher · View at Google Scholar
  66. S. Ramia, N. M. Melhem, and K. Kreidieh, “Hepatitis C virus infection in the Middle East and North Africa ‘mENA’ region: injecting drug users (IDUs) is an under-investigated population,” Infection, vol. 40, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Elhadi, A. Elbadawi, S. Abdelrahman et al., “Integrated bio-behavioural HIV surveillance surveys among female sex workers in Sudan, 2011-2012,” Sexually Transmitted Infections, vol. 89, supplement 3, pp. iii17–iii22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. M. A. Daw, A. Shabash, A. El-Bouzedi, and A. A. Dau, “Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya,” PLoS ONE, vol. 9, no. 6, Article ID e98793, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. L. J. Abu-Raddad, K. G. Ghanem, A. Feizzadeh, H. Setayesh, J. M. G. Calleja, and G. Riedner, “HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress?” Sexually Transmitted Infections, vol. 89, supplement 3, pp. iii1–iii4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. A. P. Jimenez, M. K. Mohamed, N. S. Eldin et al., “Injection drug use is a risk factor for HCV infection in urban Egypt,” PLoS ONE, vol. 4, no. 9, Article ID e7193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. N. S. Shalaka, N. A. Garred, H. T. Zeglam et al., “Clinical profile and factors associated with mortality in hospitalized patients with HIV/AIDS: a retrospective analysis from Tripoli Medical Centre, Libya, 2013,” Eastern Mediterranean Health Journal, vol. 21, no. 9, pp. 635–646, 2015. View at Google Scholar · View at Scopus
  72. World Health Organization, “Global Status Report on Alcohol 2004,” 2004, http://www.who.int/substance_abuse/publications/global_status_report_2004_overview.pdf.
  73. O. Bahri, S. Ezzikouri, B. Alaya-Bouafif et al., “First multicenter study for risk factors for hepatocellular carcinoma development in North Africa,” World Journal of Hepatology, vol. 3, no. 1, pp. 24–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Khan and M. J. Hashim, “Burden of virus-associated liver cancer in the Arab world, 1990–2010,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 1, pp. 265–270, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Agnello and F. G. De Rosa, “Extrahepatic disease manifestations of HCV infection: some current issues,” Journal of Hepatology, vol. 40, no. 2, pp. 341–352, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. A. L. Zignego, C. Ferri, S. A. Pileri, P. Caini, and F. B. Bianchi, “Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach,” Digestive and Liver Disease, vol. 39, no. 1, pp. 2–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. M. A. Daw, A. Shabash, A. El-Bouzedi, A. A. Dau, M. Habas, and Libyan-Study-Group-of-Hepatitis-and-HIV, “Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: an investigation of providing a preventive strategy,” World Journal of Virology, vol. 5, no. 1, pp. 14–22, 2016. View at Publisher · View at Google Scholar
  78. I. Waked, W. Doss, M. H. El-Sayed et al., “The current and future disease burden of chronic hepatitis C virus infection in Egypt,” Arab Journal of Gastroenterology, vol. 15, no. 2, pp. 45–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. M. A. Daw, A. El-Bouzedi, M. O. Ahmed, A. A. Dau, and M. M. Agnan, “Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa,” Travel Medicine and Infectious Disease, 2016. View at Publisher · View at Google Scholar
  80. M. A. Daw, A. El-Bouzedi, M. O. Ahmed, A. A. Dau, M. M. Agnan, and A. M. Drah, “Geographic integration of hepatitis C virus: a global threat,” World Journal of Virology (WJV), 2016. View at Google Scholar